For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe7073Ya&default-theme=true
RNS Number : 7073Y Netcall PLC 31 March 2026
31 March 2026
NETCALL PLC
("Netcall", the "Company" or the "Group")
Director/PDMR Dealing
Netcall plc (AIM: NET), an enterprise software company that unites automation
and customer engagement in one AI-powered platform, announces the purchase of
10,000 ordinary shares of 5 pence each ("Ordinary Shares") by Henrik Bang,
Non-Executive Chair, the purchase of 25,000 Ordinary Shares by James
Ormondroyd, Chief Executive Officer, and the purchase of 50,000 Ordinary
Shares by James Platt, Non-Executive Director.
Following the purchase of 10,000 Ordinary Shares, Mr Bang's shareholding is
4,473,777 Ordinary Shares, representing 2.62 per cent. of the total voting
rights of the Company. Following the purchase of 25,000 Ordinary Shares, Mr
Ormondroyd's shareholding is 3,117,604 Ordinary Shares, representing 1.83 per
cent. of the total voting rights of the Company. Following the purchase of
50,000 Ordinary Shares, Mr Platt's shareholding is 145,279 Ordinary Shares,
representing 0.08 per cent. of the total voting rights of the Company.
For further enquiries, please contact:
Netcall plc Tel. +44 (0) 330 333 6100
James Ormondroyd, CEO
Richard Hughes, CFO
Henrik Bang, Non-Executive Chair
Tel. +44 (0) 20 7523 8000
Canaccord Genuity Limited (Nominated Adviser and Joint Broker)
Simon Bridges / Harry Gooden / Andrew Potts / Elizabeth Halley-Stott
Singer Capital Markets (Joint Broker) Tel. +44 (0) 20 7496 3000
Charles Leigh-Pemberton / James Moat / Anastassiya Eley
Alma Strategic Communications Tel. +44 (0) 20 3405 0205
Caroline Forde / Hilary Buchanan / Emma Thompson
About Netcall
Netcall (AIM: NET) is a UK-based enterprise software company that unites
automation and customer engagement in one AI-powered platform. Its Liberty
platform makes work easier by digitising processes and simplifying customer
interactions in a single, easy-to-use solution that reduces complexity. Today,
around 700 organisations across healthcare, government and financial services
depend on Netcall for business‑critical workflows, including two‑thirds of
NHS Acute Health Trusts, one half of UK local authorities and major
enterprises such as Legal & General, Baloise and Santander. For further
information, please go to www.netcall.com (http://www.netcall.com) .
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Henrik Bang
2. Reason for the Notification
a) Position/status Non-Executive Chair
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
b) LEI 213800GZHEAA98QBJY98
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary Shares
Identification code GB0000060532
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s) Price(s) Volume(s)
96.77 p 10,000
d) Aggregated information: N/A - single transaction
Aggregated volume
Price
e) Date of the transaction 30 March 2026
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information:
Aggregated volume
Price
N/A - single transaction
e)
Date of the transaction
30 March 2026
f)
Place of the transaction
London Stock Exchange (XLON)
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name James Ormondroyd
2. Reason for the Notification
a) Position/status Chief Executive Officer
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
b) LEI 213800GZHEAA98QBJY98
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary Shares
Identification code GB0000060532
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s) Price(s) Volume(s)
96.90 p 25,000
d) Aggregated information: N/A - single transaction
Aggregated volume
Price
e) Date of the transaction 30 March 2026
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information:
Aggregated volume
Price
N/A - single transaction
e)
Date of the transaction
30 March 2026
f)
Place of the transaction
London Stock Exchange (XLON)
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name James Platt
2. Reason for the Notification
a) Position/status Non-Executive Director
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
b) LEI 213800GZHEAA98QBJY98
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary Shares
Identification code GB0000060532
b) Nature of the transaction Purchase of ordinary shares
c) Price(s) and volume(s) Price(s) Volume(s)
98.40 p 50,000
d) Aggregated information: N/A - single transaction
Aggregated volume
Price
e) Date of the transaction 30 March 2026
f) Place of the transaction London Stock Exchange (XLON)
d)
Aggregated information:
Aggregated volume
Price
N/A - single transaction
e)
Date of the transaction
30 March 2026
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDZGFFNGGGVZM
Copyright 2019 Regulatory News Service, all rights reserved